BIOGEN INC. Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions
BIOGEN INC. (BIIB) reported Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions of $25.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-03.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions · last filed 2017-02-02
- BIOGEN INC. unrecognized tax benefits, decrease resulting from current period tax positions for the quarter ending 2015-03-31 was $27.00M.
- BIOGEN INC. unrecognized tax benefits, decrease resulting from current period tax positions for the quarter ending 2014-12-31 was -$100.00K.
- BIOGEN INC. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2015 was $25.00M, a 1150.00% increase from fiscal 2014.
- BIOGEN INC. unrecognized tax benefits, decrease resulting from current period tax positions for fiscal 2014 was $2.00M.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 3 month | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 6 month | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 9 month | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions 12 month |
|---|---|---|---|---|
| 2015-12-31 | $25.00M 10-K · filed 2016-02-03 | |||
| 2015-03-31 | $27.00M 10-K · filed 2017-02-02 | $26.90M derived: sum of 2 quarters · filed 2017-02-02 | ||
| 2014-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $2.00M 10-K · filed 2015-02-04 | ||
| 2014-09-30 | $2.10M 10-Q · filed 2014-10-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |